Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Psilocybin for Depression Study Approved and Funded by German Government

Psilocybin for Depression Study Approved and Funded by German Government

  • Post published:November 19, 2020
  • Post category:Clinical Trials/News
Read more about the article Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks

Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks

  • Post published:November 14, 2020
  • Post category:Clinical Trials/Research
Read more about the article Phase 2 Clinical Trial to Evaluate Safety and Efficacy of Psilocybin in Cancer Patients with Major Depressive Disorder

Phase 2 Clinical Trial to Evaluate Safety and Efficacy of Psilocybin in Cancer Patients with Major Depressive Disorder

  • Post published:October 22, 2020
  • Post category:Clinical Trials/News
Read more about the article First Psilocybin for Depression Clinical Trial Launched in Sweden

First Psilocybin for Depression Clinical Trial Launched in Sweden

  • Post published:October 16, 2020
  • Post category:Clinical Trials/News
Read more about the article Can Taking MDMA with LSD Help Prevent a ‘Bad Trip’? New Clinical Trial Investigates

Can Taking MDMA with LSD Help Prevent a ‘Bad Trip’? New Clinical Trial Investigates

  • Post published:August 19, 2020
  • Post category:Clinical Trials/News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More